IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Phase II Clinical Results and Capital Raising Presentation, page-18

  1. 8,422 Posts.
    lightbulb Created with Sketch. 1386
    It's true that the significance at all durations is at 90%, not at 95%.

    But if the identical results were observed in a larger sample, it would be significant at 95%.

    As for longer durations, we can only speculate.

    IMO safety isn't an issue because it's being repurposed.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.001(1.43%)
Mkt cap ! $5.335M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $2.546K 35.86K

Buyers (Bids)

No. Vol. Price($)
1 14158 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 5000 1
View Market Depth
Last trade - 14.37pm 31/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.